Compare Medtronic PLC (MDT) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Paycom Software Inc — how do they compare? Medtronic PLC trades at $82.67 (market cap $106.61B), while Paycom Software Inc trades at $144.2 (market cap $6.98B). The key difference: Medtronic PLC is far larger — about 15.3× Paycom Software Inc's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | PAYC | |
|---|---|---|
Market Cap | $106.61B | $6.98B |
Sector | Health | Technology |
52-Week High | $105.35 | $238.80 |
52-Week Low | $73.75 | $113.59 |
Enterprise Value | $125.36B | $7.59B |
Dividend Yield | 3.46% | 1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Paycom Software (PAYC) trades at $149.71, up 1.2% with a bullish technical signal supported by moving averages. The company shows strong profitability with 22.44% net income margin and 37.15% ROE, though recent Q3 2025 EPS slightly missed expectations. Recent developments include new asset management tool launches and board appointments, while analyst consensus sits at $151 price target with 47% buy ratings.
PAYC presents a balanced investment case with solid fundamentals and moderate valuation (P/E 17.12), though execution risks and competitive pressures in HCM software require monitoring. The stock's proximity to resistance at $152 suggests near-term consolidation potential, while earnings growth remains the key catalyst for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
